National Center for Advancing Translational Sciences |

U.S. Department of Health & Human Services

Illustration of a cytokine storm response to infection with the new coronavirus SARS-CoV-2.

NCATS-Supported Clinical Trial Shows Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19

The ACTIV-1 Immune Modulators clinical trial found that two immune modulator drugs substantially improved clinical status and reduced deaths for adults hospitalized with COVID-19.

Learn More

Our focus is to advance the science of translation, which is the process of turning observations into interventions to improve health.

We work with researchers, the public and other stakeholder groups to design new approaches and technologies that ultimately will deliver more treatments to more people more quickly. Read more

In the Spotlight See more spotlights

Transmission electron micrograph of SARS-CoV-2 virus particles.

Scientists Identify Characteristics to Better Define Long COVID

Read and Share the Latest Newsletter

Scanning electron microscope image of SARS-CoV-2.

Stay Up to Date with NCATS’ Response to COVID-19

Graphic with a scientist in a lab coat holding a flask with science-related icons superimposed over the top in the background. LITCOIN is written in the foreground.

New LitCoin Design Challenge Announced

Photo of P.J. Brooks, Ph.D., and Joni L. Rutter, Ph.D., raising their hands in front of the lit-up Building 38A on the NIH main campus.

Rare Disease Day at NIH Shines a Light on Patient Perspectives

A compound blocks a hormone from its receptor.

Scientists Find Compound to Potentially Help Regulate a Key Brain Chemical in Drug Addiction

Close up of two people signing an agreement.

Nationwide IRB Agreement Reaches 1,000 Signatories

Antibodies attach to Schwann cells and motoneurons.

SBIR–Supported Researchers Create Tissue Chip Model for Rare Neuromuscular Disorders

Female doctor uses a stethoscope to measure a child’s heartbeat in a doctor’s office.

NCATS Supports Research to Shorten the Rare Diseases Diagnostic Odyssey

Director's Corner

Joni L. Rutter, Ph.D.

Director’s Message

June 8, 2022: Increase Inclusivity to Improve Health for All

To achieve the vision of bringing more treatments to all people more quickly, NCATS must dramatically increase inclusivity across every area it supports. NCATS Acting Director Joni Rutter, Ph.D., shares how the Center is working toward this goal.

Read Full Message

In the Spotlight See more spotlights

Director's Corner

Director’s Message

June 8, 2022: Increase Inclusivity to Improve Health for All

Resources For You

For Researchers

For the Public